Keeping Clinical Trials on Schedule
A clinical trial can stall for a surprisingly simple reason. The medicines it needs, from the comparator drug to the ancillary supplies, don't arrive on time or don't come with the right records.
Phatebo's Role in Clinical Trial Supply
Phatebo was built to prevent exactly that. The German company sources investigational, comparator and ancillary medicines through licensed channels for pharma companies and CROs, with complete records of origin, batch and expiry.
HRV Pharma's Acquisition of Phatebo
As News18 reports, HRV Pharma is acquiring Phatebo, a business that earned around ₹350 crore in 2025, from ZeroStack Corp. The deal gives HRV its first finished formulations business and a foothold in Europe.
Business Continuity for Existing Customers
For sponsors already working with Phatebo, nothing changes on the ground. The company keeps its name, its team and its customer agreements.
Featured in News18
